CHUM Research Centre
514 890-8000, ext. 12732
The patient who needs immediate assistance should not communicate directly with the researcher. Instead, they should call the doctor’s office or take other appropriate measures, such as going to the nearest emergency service.
Department of microbiolgy, infectiology and immunology, University of Montreal
Cancer, oncolytic viruses, immunotherapy, anti-cancer vaccination, breast cancer, leukemia.
Our research team studies the use of oncolytic viruses for cancer immunotherapy.
More specifically, our research program includes 3 main facets:
- The use of oncolytic viruses as platforms for personalized anti-cancer vaccination
- The development of novel vaccination strategies using oncolytic viruses and bacteria
- The study of the role of the immunoproteasome for the immunotherapeutic activity of oncolytic viruses